Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Acute-on-Chronic Liver Failure: A New and Important Entity in the ICU

  • Chapter
  • First Online:
Practical Trends in Anesthesia and Intensive Care 2017

  • 964 Accesses

Abstract

Traditionally two types of liver failure were recognized: acute liver failure (ALF), characterized by a rapid deterioration of the liver function in the absence of a preexisting liver disease, and the progression with a slow deterioration over time of preexisting end-stage liver disease leading to an acute hepatic insult [1]. Recently, a new clinical form of liver failure has been described: Acute-on-chronic liver failure (ACLF). This new entity is characterized by acute complications of compensated or even decompensated cirrhosis with a high rate of organ failure and a high short-term mortality rate. ACLF is now an increasingly recognized entity in both the hepatology and critical care literature and poses several challenges to clinicians. In fact, the liver’s position at the apex of multiple synthetic, detoxifying, metabolic, immunological, and hormonal processes predisposes patients with ACLF to a number of complications. The present review aims at summarizing the most updated knowledge about this particularly severe syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez CM. Acute-on-chronic liver failure: pathogenesis, prognostic factors and management. World J Gastroenterol. 2015;21:12125–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the liver (APASL). Hepatol Int. 2009;3:269–82.

    Article  PubMed  Google Scholar 

  3. Jalan R, Gines P, Olson JC, et al. Acute-on-chronic liver failure. J Hepatol. 2012;57:1336–48.

    Article  PubMed  Google Scholar 

  4. Levesque E, Hoti E, Azoulay D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol. 2012;56:95–102.

    Article  PubMed  Google Scholar 

  5. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–37.

    Article  PubMed  Google Scholar 

  6. Arroyo V, Moreau R, Jalan R, Ginès P, On behalf of the investigators of the EASL-CLIF consortium CANONIC study. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62:S131–43.

    Article  PubMed  Google Scholar 

  7. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012;335:936–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006;43:S54–62.

    Article  CAS  PubMed  Google Scholar 

  9. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14:996–1006. 41-43

    Article  CAS  PubMed  Google Scholar 

  10. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385–96.

    Article  CAS  PubMed  Google Scholar 

  11. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42:195–201.

    Article  CAS  PubMed  Google Scholar 

  12. Adebayo D, Morabito V, Andreola F, Pieri G, Luong TV, Dhillon A, Mookerjee R, Jalan R. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study. Liver Int. 2015;35:2564–74.

    Article  CAS  PubMed  Google Scholar 

  13. Karvellas CJ, Pink F, McPhail M, et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2009;38:121–6.

    Article  Google Scholar 

  14. Berry PA, Antoniades CG, Carey I, et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med. 2011;37:453–60.

    Article  CAS  PubMed  Google Scholar 

  15. Bajaj JS, O’Leary JG, Reddy KR, on behalf of NACSELD, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the north American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56:2328–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Galbois A, Aegerter P, Martel-Samb P. Improved prognosis of septic shock in patients with cirrhosis: a multicenter study. Crit Care Med. 2014;42:16666–1675.

    Article  Google Scholar 

  17. Møller S, Krag A, Bendtsen F. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int. 2014;34:1153–63.

    Article  PubMed  Google Scholar 

  18. Dundar HZ, Yılmazlar T. Management of hepatorenal syndrome. World J Nephrol. 2015;4:277–86.

    Article  PubMed  PubMed Central  Google Scholar 

  19. DellaVolpe J, Garavaglia JM, Huang DT. Management of complications of end-stage liver disease in the intensive care unit. J Int Care Med. 2016;31:94–103.

    Article  Google Scholar 

  20. Wong F, O’Leary JG, Reddy KR, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145:1280–8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol. 2015;21:11502–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Olson JC, Wendon JA, Kramer DJ, et al. Intensive care of the patient with cirrhosis. Hepatology. 2011;54:1864–72.

    Article  PubMed  Google Scholar 

  23. Liu A, Perumpail RB, Kumari R, et al. Advances in cirrhosis: optimizing the management of hepatic encephalopathy. World J Hepatol. 2015;7:2871–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Raevens S, Geerts A, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Colle I. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int. 2015;35:1646–60.

    Article  PubMed  Google Scholar 

  25. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol. 2010;23:145–50.

    Article  PubMed  Google Scholar 

  26. Schadena E, Saner FH, Goerlinger K. Coagulation pattern in critical liver dysfunction. Curr Opin Crit Care. 2013;19:142–8.

    Article  Google Scholar 

  27. Karvellas CJ, Bagshaw SM. Advances in management and prognostication in critically ill cirrhotic patients. Curr Opin Crit Care. 2014;20:210–7.

    Article  PubMed  Google Scholar 

  28. Chan AC, Fan ST. Criteria for liver transplantation in ACLF and outcome. Hepatol Int. 2015;9:355–9.

    Article  PubMed  Google Scholar 

  29. Reddy MS, Rajalingam R, Rela M. Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting. Hepatol Int. 2015;9:508–13.

    Article  PubMed  Google Scholar 

  30. Finkenstedt A, Nachbaur K, Zoller H, et al. Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl. 2013;19:879–86.

    Article  PubMed  Google Scholar 

  31. Bahirwani R, Shaked O, Bewtra M, et al. Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes. Transplantation. 2011;92:952–7.

    Article  PubMed  Google Scholar 

  32. Kress JP, Rubin A, Pohlman A, Hall JB. Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med. 2000;162:418–23.

    Article  CAS  PubMed  Google Scholar 

  33. Arabi YM, Dara SI, Memish Z, et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology. 2012;56:2305–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–77.

    Article  PubMed  Google Scholar 

  35. Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis. Hepatology. 2009;50:2022–33.

    Article  CAS  PubMed  Google Scholar 

  36. Nadim MK, Durand F, Kellum JA, et al. Management of the critically ill patient with cirrhosis: a multidisciplinary perspective. J Hepatol. 2016;64:717–35.

    Article  PubMed  Google Scholar 

  37. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, doubleblind,placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134:1360–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134:1352–9.

    Article  CAS  PubMed  Google Scholar 

  39. Biancofiore G, Critchley LA, Lee A, et al. Evaluation of a new software version of the FloTrac/Vigileo (version 3.02) and a comparison with previous data in cirrhotic patients undergoing liver transplant surgery. Anesth Analg. 2011;113:515–22.

    PubMed  Google Scholar 

  40. Sharma BC, Sharma P, Lunia MK, et al. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108:1458–63.

    Article  CAS  PubMed  Google Scholar 

  41. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6:443–50.

    Article  CAS  PubMed  Google Scholar 

  42. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004;10:174–82.

    Article  PubMed  Google Scholar 

  43. Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–62.

    Article  PubMed  Google Scholar 

  44. Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplant Anesthesia and Critical Care Department, Azienda Ospedaliera Universitaria Pisana, Pisana, Italy

    Gianni Biancofiore

  2. Anesthesiolgy and Critical Care, University School of Medicine, Pisa, Italy

    Gianni Biancofiore

Authors
  1. Gianni Biancofiore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianni Biancofiore .

Editor information

Editors and Affiliations

  1. Department of “Scienze della Salute”, University of Milan, Milan, Italy

    Davide Chiumello

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Biancofiore, G. (2018). Acute-on-Chronic Liver Failure: A New and Important Entity in the ICU. In: Chiumello, D. (eds) Practical Trends in Anesthesia and Intensive Care 2017. Springer, Cham. https://doi.org/10.1007/978-3-319-61325-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61325-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61324-6

  • Online ISBN: 978-3-319-61325-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation